Skip to main content
West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
248.06
+2.20 (0.89%)
At close: Mar 9, 2026, 4:00 PM EDT
248.06
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:30 PM EDT

WST Revenue

In the year 2025, West Pharmaceutical Services had annual revenue of $3.07B with 6.25% growth. West Pharmaceutical Services had revenue of $805.00M in the quarter ending December 31, 2025, with 7.51% growth.

Revenue (ttm)
$3.07B
Revenue Growth
+6.25%
P/S Ratio
5.81
Revenue / Employee
$284,639
Employees
10,800
Market Cap
17.87B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.07B180.90M6.25%
Dec 31, 20242.89B-56.60M-1.92%
Dec 31, 20232.95B62.90M2.18%
Dec 31, 20222.89B55.30M1.95%
Dec 31, 20212.83B684.70M31.89%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Becton, Dickinson and Company 21.92B
Baxter International 11.24B
Alcon 10.40B
Solventum 8.33B
ResMed 5.40B
Bausch + Lomb 5.10B
The Cooper Companies 4.15B
Hologic 4.13B
Revenue Rankings

WST News

More News